Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
FDA-approved weight loss options Weekly GLP-1 medications: Mounjaro (tirzepatide): 16-22% weight loss Wegovy (semaglutide): Typically, 15% weight loss Zepbound (tirzepatide): Often 20-23% weight loss Why starting GLP-1s now makes sense Obesity increases risks for type 2 diabetes, heart failure, cardiovascular disease, and other serious conditions
It is important to note that Hers does not accept insurance and instead operates on a subscription model
Spring and fall travel Moderate seasons are the easiest for GLP-1 travel
The Melanotan-1 fda approved status is unambiguous
Patients who failed to meet specific glycemic goals during the studies were treated with metformin rescue, added on to placebo or Januvia
